A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

Clinical trial NCT00314938 · TERMINATED

Trial details

NCT number: NCT00314938
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2006-04-01
Primary completion: 2007-11-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.